Thu. Nov 7th, 2024

Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc.; ViewRay, Inc.; 9 Meters Biopharma, Inc.; Nabriva Therapeutics plc; UTA Acquisition Corporation; AppHarvest, Inc.; Yellow Corporation; Proterra Inc.; Amy

Sep 7, 2023

NEW YORK , Sept. 07, 2023 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of Nymox Pharmaceutical Corporation. Nymox Pharmaceutical Corporation’s securities were suspended on July 7, 2023 , and have not traded on Nasdaq since that time.